Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501711 | SCV000593977 | likely benign | not specified | 2021-03-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765317 | SCV000896573 | uncertain significance | Meier-Gorlin syndrome 4 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000974644 | SCV001122478 | likely benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000974644 | SCV002498197 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | CDT1: BP4, BS2 |
Prevention |
RCV003962371 | SCV004786188 | likely benign | CDT1-related disorder | 2023-10-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |